The Clinical Outcomes and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and HR+/HER2-Breast Cancer: A Multicenter Observational Study from Turkey
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.3390/cancers17091592
dc.identifier.other
WOS:001486131800001
dc.description.volume
dc.description.issue
Publisher
MDPI
DOI
10.3390/cancers17091592